Remove after-splashing-1b-roche-returns-lagging-cancer-drug-gavreto-blueprint
article thumbnail

After splashing $1B, Roche returns lagging cancer drug Gavreto to Blueprint Medicines

Fierce Pharma

After splashing $1B, Roche returns lagging cancer drug Gavreto to Blueprint Medicines aliu Thu, 02/23/2023 - 11:14

Medicine 238